A move to strengthen the rights of companies to restrict access to databases they compile has touched a raw nerve among science officials in Washington. This month the presidents of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine warned that a proposal to be discussed at upcoming international trade talks in Geneva could make it harder and more expensive for scientists to gain access to data.